Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is a randomized, open-label multi-center evaluation of the tolerability of
treatment with NGX-4010 in conjunction with pre-patch topical application of one of three 4%
lidocaine-based local anesthetic products. Eligible subjects will have moderate to severe
neuropathic pain secondary to painful diabetic neuropathy (PDN), postherpetic neuralgia (PHN)
or HIV-associated neuropathy (HIV-AN), with average numeric pain rating scale (NPRS) scores
during screening of 3 to 8 (inclusive).